Pierre Mordant
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pierre Mordant has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
Hervé Mal
Pneumology and Lung Transplantation Department, Bichat Hospital, AP-HP , Paris, 75018
3 shared publications- Jonathan Messika
Université Paris Cité Inserm, Centre de recherche sur l'inflammation Paris France
3 shared publications - Vincent Bunel
APHP Nord-Université Paris Cité, Hôpital Bichat, Service de Pneumologie B et Transplant Pulmonaire, Université Paris Cité, UMR 1149, Centre de Recherche de l'Inflammation, 75018, France
3 shared publications A. Bizot
2 shared publications- Antoine Girault
Department of Vascular and Thoracic Surgery, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
2 shared publications Arnaud Roussel
APHP, CHU Bichat-Claude Bernard, Service de Chirurgie Thoracique et Vasculaire, 46 Rue Henri Huchard, 75018 Paris, France
2 shared publications
Latest Publications
- 9 July 2026
- Published by The Korean Society of Anesthesiologists in Anesthesia and Pain Medicine
Intercostal nerve cryoanalgesia in lung transplantation: a retrospective single-center study
Background: Pain management after lung transplantation (LT) is challenging, with most cen-ters using a multimodal analgesia approach that includes opioids and thoracic epidural analge-sia (TEA). Intercostal nerve cryoanalgesia (INCA), which blocks peripheral nerves to provide pain control for about two months, is gaining popularity worldwide but has rarely been stud-ied in the context of LT.Methods: Retrospective, before-and-after single-center study conducted between October 2024 and July 2025. A group without INCA (PRE-INCA) was compared to a group with INCA (POST-INCA). All patients received TEA and multimodal analgesia. The primary out-come was the total consumption of oral morphine milligram equivalents (MMEs) between Day 1 and Day 28.Results: We included 28 consecutive LT recipients, among whom 14 received INCA. Pa-tients’ baseline characteristics were similar across groups. Patients in the POST-INCA group received significantly fewer opioids during the first 28 days (PRE-INCA 1,499 [972, 1,909] MME vs. POST-INCA 543 [153, 1,050] MME; P = 0.004). Moreover, at month 1, basal pain was significantly reduced in the POST-INCA group (Numeric Rating Scale [NRS] PRE-INCA 2.25 [0.00, 4.50] vs. NRS POST-INCA 0.00 [0.00, 0.00]; P = 0.010). Other clinical outcomes, including duration of mechanical ventilation, length of stay, forced expiratory value at 1 s, and mortality, were similar between the groups.Conclusions: Adding INCA to TEA is associated with a significant reduction in opioid con-sumption and postoperative pain during the first 28 days following LT. These results should be interpreted with caution due to the retrospective, single-center design and the small sample size of the study.
- 9 July 2026
- Published by The Korean Society of Anesthesiologists in Anesthesia and Pain Medicine
Intercostal nerve cryoanalgesia in lung transplantation: a retrospective single-center study
Background: Pain management after lung transplantation (LT) is challenging, with most cen-ters using a multimodal analgesia approach that includes opioids and thoracic epidural analge-sia (TEA). Intercostal nerve cryoanalgesia (INCA), which blocks peripheral nerves to provide pain control for about two months, is gaining popularity worldwide but has rarely been stud-ied in the context of LT.Methods: Retrospective, before-and-after single-center study conducted between October 2024 and July 2025. A group without INCA (PRE-INCA) was compared to a group with INCA (POST-INCA). All patients received TEA and multimodal analgesia. The primary out-come was the total consumption of oral morphine milligram equivalents (MMEs) between Day 1 and Day 28.Results: We included 28 consecutive LT recipients, among whom 14 received INCA. Pa-tients’ baseline characteristics were similar across groups. Patients in the POST-INCA group received significantly fewer opioids during the first 28 days (PRE-INCA 1,499 [972, 1,909] MME vs. POST-INCA 543 [153, 1,050] MME; P = 0.004). Moreover, at month 1, basal pain was significantly reduced in the POST-INCA group (Numeric Rating Scale [NRS] PRE-INCA 2.25 [0.00, 4.50] vs. NRS POST-INCA 0.00 [0.00, 0.00]; P = 0.010). Other clinical outcomes, including duration of mechanical ventilation, length of stay, forced expiratory value at 1 s, and mortality, were similar between the groups.Conclusions: Adding INCA to TEA is associated with a significant reduction in opioid con-sumption and postoperative pain during the first 28 days following LT. These results should be interpreted with caution due to the retrospective, single-center design and the small sample size of the study.
- Open Access
- 5 May 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (5)
Association Between Pre-Transplant Psoas Sarcopenia and Perioperative Outcomes in Lung Transplant Recipients: A Single-Centre Retrospective Cohort Study
Objectives: Lung transplantation (LTx) is the solid organ transplantation with the comparatively worst prognosis. Therefore, improving candidate selection and risk stratification for these patients has become a high-priority research focus. Incorporating objective markers of frailty such as sarcopenia in the pretransplant evaluation may help achieve this goal. We evaluated the association between CT-measured psoas muscle sarcopenia and early LTx outcomes. Methods: We performed a retrospective study including patients who underwent LTx from 2014 to 2018 at our institution with available chest and abdominal CT scans in the year prior to LTx. The psoas cross-sectional area was measured, and previously established sex-specific cutoffs were used to define sarcopenia. We compared sarcopenic and non-sarcopenic LTx recipients regarding 1-year mortality and perioperative outcomes. Results: A total of 140 patients were included, who received LTx primarily for interstitial lung disease (ILD) (n = 75, 53%) or chronic obstructive pulmonary disease (n = 54, 39%). Forty-six (33%) were sarcopenic. We found no association between psoas sarcopenia and 1-year all-cause mortality (multivariable P = .13) nor perioperative complications or FEV1 at 1 year post-LTx. Exploratory subgroup analysis revealed an association between psoas sarcopenia and 1-year all-cause mortality in patients with ILD (multivariable P = .042). Conclusions: Pre-established sex-specific cutoffs for psoas sarcopenia did not reach statistical significance for 1-year mortality or perioperative outcomes in the overall cohort; given the limited statistical power, a clinically meaningful association cannot be excluded. An exploratory signal in ILD patients warrants further investigation. Future studies may benefit from disease-specific threshold validation and the integration of muscle strength and physical performance alongside muscle mass assessment.
- 5 May 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (5)
Open AccessAssociation Between Pre-Transplant Psoas Sarcopenia and Perioperative Outcomes in Lung Transplant Recipients: A Single-Centre Retrospective Cohort Study
Objectives: Lung transplantation (LTx) is the solid organ transplantation with the comparatively worst prognosis. Therefore, improving candidate selection and risk stratification for these patients has become a high-priority research focus. Incorporating objective markers of frailty such as sarcopenia in the pretransplant evaluation may help achieve this goal. We evaluated the association between CT-measured psoas muscle sarcopenia and early LTx outcomes. Methods: We performed a retrospective study including patients who underwent LTx from 2014 to 2018 at our institution with available chest and abdominal CT scans in the year prior to LTx. The psoas cross-sectional area was measured, and previously established sex-specific cutoffs were used to define sarcopenia. We compared sarcopenic and non-sarcopenic LTx recipients regarding 1-year mortality and perioperative outcomes. Results: A total of 140 patients were included, who received LTx primarily for interstitial lung disease (ILD) (n = 75, 53%) or chronic obstructive pulmonary disease (n = 54, 39%). Forty-six (33%) were sarcopenic. We found no association between psoas sarcopenia and 1-year all-cause mortality (multivariable P = .13) nor perioperative complications or FEV1 at 1 year post-LTx. Exploratory subgroup analysis revealed an association between psoas sarcopenia and 1-year all-cause mortality in patients with ILD (multivariable P = .042). Conclusions: Pre-established sex-specific cutoffs for psoas sarcopenia did not reach statistical significance for 1-year mortality or perioperative outcomes in the overall cohort; given the limited statistical power, a clinically meaningful association cannot be excluded. An exploratory signal in ILD patients warrants further investigation. Future studies may benefit from disease-specific threshold validation and the integration of muscle strength and physical performance alongside muscle mass assessment.
- Open Access
- 1 October 2025
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
- Vol. 39 (4) , 378-383
Refractory antibody-mediated rejection after high-emergency lung transplantation for dermatomyositis with anti-MDA5 antibody: a case report
Louise Chantelot, Domitille Mouren, Jean-Luc Taupin, Aurélie Cazes, Jonathan Messika, Cendrine Godet, Mathilde Salpin, Gaelle Weisenburger, Brice Lortat-Jacob, Pierre Mordant, Jean-François Alexandra, Raphael Borie, Chloé Comarmond, Yves Allenbach, Yurdagül Uzunhan, Hervé Mal, Antoine Roux, Vincent Bunel. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0034
- 1 October 2025
- Published by The Korean Society for Transplantation in Clinical Transplantation and Research
- Vol. 39 (4) , 378-383
Open AccessRefractory antibody-mediated rejection after high-emergency lung transplantation for dermatomyositis with anti-MDA5 antibody: a case report
Louise Chantelot, Domitille Mouren, Jean-Luc Taupin, Aurélie Cazes, Jonathan Messika, Cendrine Godet, Mathilde Salpin, Gaelle Weisenburger, Brice Lortat-Jacob, Pierre Mordant, Jean-François Alexandra, Raphael Borie, Chloé Comarmond, Yves Allenbach, Yurdagül Uzunhan, Hervé Mal, Antoine Roux, Vincent Bunel. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.25.0034
- 21 February 2025
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 44 (2) , 101499
Time on the waiting list is an independent risk factor for day-90 mortality after lung transplantation
- 21 February 2025
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 44 (2) , 101499
Time on the waiting list is an independent risk factor for day-90 mortality after lung transplantation
- Open Access
- 21 June 2024
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (10) , 1727-1736
Outcomes of lung transplantation for pleuroparenchymal fibroelastosis: A French multicentric retrospective study
- 21 June 2024
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (10) , 1727-1736
Open AccessOutcomes of lung transplantation for pleuroparenchymal fibroelastosis: A French multicentric retrospective study
- 15 October 2022
- Published by Elsevier in Revue des Maladies Respiratoires Actualités
- Vol. 14 (2) , 2S338-2S350
Populations particulières : patients de Performance Status 2 ou plus
- 15 October 2022
- Published by Elsevier in Revue des Maladies Respiratoires Actualités
- Vol. 14 (2) , 2S338-2S350
Populations particulières : patients de Performance Status 2 ou plus
- 15 October 2022
- Published by Elsevier in Revue des Maladies Respiratoires Actualités
- Vol. 14 (2) , 2S46-2S58
Bilan du cancer broncho-pulmonaire non à petites cellules : quel bilan anatomique ?
- 15 October 2022
- Published by Elsevier in Revue des Maladies Respiratoires Actualités
- Vol. 14 (2) , 2S46-2S58
Bilan du cancer broncho-pulmonaire non à petites cellules : quel bilan anatomique ?
- 1 January 2021
- Published by Elsevier in Revue des Maladies Respiratoires Actualités
- Vol. 13 (1) , 46
Infections à Corynébactéries non diphtériques et complications bronchiques après transplantation pulmonaire – une étude cas-témoin
- 1 January 2021
- Published by Elsevier in Revue des Maladies Respiratoires Actualités
- Vol. 13 (1) , 46
Infections à Corynébactéries non diphtériques et complications bronchiques après transplantation pulmonaire – une étude cas-témoin